US approves updated Pfizer, Moderna shots targeting Omicron / Photo: Joseph Prezioso - AFP/File
RBGPF
0.5000
Dubai Telegraph - US approves updated Pfizer, Moderna shots targeting Omicron
EUR
-
AED 4.306431
AFN 75.047853
ALL 95.509472
AMD 434.781696
ANG 2.098846
AOA 1076.460889
ARS 1633.493713
AUD 1.626689
AWG 2.110707
AZN 1.988156
BAM 1.957912
BBD 2.36228
BDT 143.909369
BGN 1.956042
BHD 0.442838
BIF 3489.702447
BMD 1.172615
BND 1.496135
BOB 8.104331
BRL 5.814063
BSD 1.17288
BTN 111.259841
BWP 15.939351
BYN 3.309739
BYR 22983.255361
BZD 2.358866
CAD 1.593784
CDF 2720.466564
CHF 0.915976
CLF 0.026807
CLP 1055.060534
CNY 8.006909
CNH 7.998882
COP 4288.546463
CRC 533.22984
CUC 1.172615
CUP 31.074299
CVE 110.753193
CZK 24.361957
DJF 208.396761
DKK 7.471833
DOP 69.741242
DZD 155.376121
EGP 62.903883
ERN 17.589226
ETB 184.100102
FJD 2.57049
FKP 0.86377
GBP 0.863156
GEL 3.142666
GGP 0.86377
GHS 13.137564
GIP 0.86377
GMD 85.601211
GNF 10289.697303
GTQ 8.960546
GYD 245.372505
HKD 9.185522
HNL 31.214689
HRK 7.533699
HTG 153.641478
HUF 362.158603
IDR 20356.18719
ILS 3.45198
IMP 0.86377
INR 111.249548
IQD 1536.125741
IRR 1540816.20108
ISK 143.785835
JEP 0.86377
JMD 183.778268
JOD 0.831419
JPY 184.308708
KES 151.443853
KGS 102.510594
KHR 4705.115487
KMF 492.498261
KPW 1055.353534
KRW 1726.651843
KWD 0.360333
KYD 0.977425
KZT 543.258636
LAK 25774.078905
LBP 105007.679148
LKR 374.851168
LRD 215.61456
LSL 19.535844
LTL 3.462427
LVL 0.709303
LYD 7.446376
MAD 10.848155
MDL 20.208266
MGA 4866.352468
MKD 61.637907
MMK 2461.893765
MNT 4195.441454
MOP 9.463996
MRU 46.869025
MUR 55.148176
MVR 18.122737
MWK 2042.108163
MXN 20.449463
MYR 4.638877
MZN 74.924153
NAD 19.535593
NGN 1613.107468
NIO 43.047128
NOK 10.873541
NPR 178.007186
NZD 1.982968
OMR 0.451158
PAB 1.17285
PEN 4.112948
PGK 5.087683
PHP 72.028464
PKR 326.895761
PLN 4.245512
PYG 7213.489671
QAR 4.272421
RON 5.186827
RSD 117.386493
RUB 87.920356
RWF 1713.776924
SAR 4.397283
SBD 9.430299
SCR 16.119145
SDG 704.156003
SEK 10.809054
SGD 1.493155
SHP 0.875476
SLE 28.843884
SLL 24589.147203
SOS 669.563404
SRD 43.923745
STD 24270.764437
STN 24.871166
SVC 10.263079
SYP 129.603259
SZL 19.535596
THB 38.097677
TJS 11.001266
TMT 4.110016
TND 3.379183
TOP 2.823376
TRY 52.990239
TTD 7.961336
TWD 37.054051
TZS 3054.662749
UAH 51.535653
UGX 4410.190424
USD 1.172615
UYU 46.77505
UZS 14012.74951
VES 573.341643
VND 30883.163084
VUV 137.959791
WST 3.183872
XAF 656.713095
XAG 0.015485
XAU 0.000255
XCD 3.169051
XCG 2.113815
XDR 0.815706
XOF 656.664578
XPF 119.331742
YER 279.78503
ZAR 19.464251
ZMK 10554.968416
ZMW 21.903218
ZWL 377.581574
- Japan PM says oil crisis has 'enormous impact' in Asia-Pacific
- Badminton no.1 An brings 'fire' as South Korea win Uber Cup
- Saka sparks Arsenal attack into life ahead of Atletico showdown
- Atletico aim to show Alvarez their ambition in Arsenal semi
- Seoul, Taipei hit records as Asian stocks track Wall St tech rally
- Boeing faces civil trial over 737 MAX crash
- North Korean club to play rare football match in South
- Pistons rout Magic to cap comeback, book NBA playoff clash with Cavaliers
- GameStop makes $56 billion takeover bid for eBay
- 'No pilgrims': regional war hushes Iraq's holy cities
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
H.El-Din--DT
